Aurobindo Pharma Share Price, fdc pharma.#Fdc #pharma

Aurobindo Pharma Ltd.

NSE Symbol: AUROPHARMA | BSE Code: 524804 | ISIN: INE406A01037 | Sector: Pharmaceuticals & Drugs

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message

Updated:23 Nov, 2017, 13:44 PM IST

Updated:23 Nov, 2017, 13:49 PM IST

Day’s Range

52 Wk Range

Day’s Range

52 Wk Range

Compare Price performance of Aurobindo Pharma vs. Peer Companies

From Pharmaceuticals & Drugs sector

  • SUNPHARMA

Color code for Price performance of and Peer companies

Aurobindo Pharma ‘s Latest Research Report

Aurobindo Pharma’s Key Fundamentals

Aurobindo Pharma’s Financial Summary

Aurobindo Pharma’s Shareholding Pattern

Aurobindo Pharma held by Mutual Fund Schemes

Aurobindo Pharma ‘s Futures and Options Quotes

Post your comments about Aurobindo Pharma

Advertisement
Advertisement

Fdc pharma

Aurobindo Pharma’s Price Swing Today

Aurobindo Pharma’s News and Announcements

Fdc pharma

Sub: Transcript of earnings call. Please refer to our letter dated 4th November 2017 wherein we have intimated the schedule of Investors/Analysts call on 10th November 2017. In this connection, we would like to inform you that the Transcript of the Q2 FY 2017-18 earnings conference call of 10th November 2017 has been uploaded on the website of the Company and is available in the following web link: http://www.aurobindo.com/docs/financial-results/2017-2018/aurobindo-pharma-q2-fy-18-earnings-call-transcript.pdf

Fdc pharma

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for K Nityananda Reddy

Fdc pharma

/Institutional Investor Meet

Fdc pharma

Aurobindo Pharma Limited has informed the Exchange regarding ‘notice of newspaper publication of transferred to Investor Education and Protection Fund (IEPF)’.

Fdc pharma

Sub: Presentation to the Investors / Analysts. We would like to inform you that the Company is participating in investors conference on 16 November 2017 in Mumbai. The attached presentation will be used in the conference. The presentation is also being uploaded on the website of the Company – http://www.aurobindo.com/investor-relations/investors/investor-presentation

Fdc pharma





Leave a Reply